發(fā)布時(shí)間:
2022
-
11
-
23
點(diǎn)擊次數(shù):
0
所屬職位：
黨委書(shū)記、董事長(zhǎng)、總經(jīng)理
所屬公司：
揚(yáng)子江藥業(yè)集團(tuán)
個(gè)人簡(jiǎn)介：
徐浩宇：現(xiàn)任揚(yáng)子江藥業(yè)集團(tuán)黨委書(shū)記、董事長(zhǎng)兼總經(jīng)理，全國(guó)工商聯(lián)醫(yī)藥業(yè)商會(huì)副會(huì)長(zhǎng)，中國(guó)醫(yī)藥質(zhì)量管理協(xié)會(huì)副會(huì)長(zhǎng)，江蘇省工商業(yè)聯(lián)合會(huì)副會(huì)長(zhǎng)，江蘇省蘇商發(fā)展促進(jìn)會(huì)常務(wù)副會(huì)長(zhǎng)，江蘇省醫(yī)藥行業(yè)協(xié)會(huì)會(huì)長(zhǎng)，曾榮獲中國(guó)長(zhǎng)三角十大杰出青商、全國(guó)QC優(yōu)秀質(zhì)量負(fù)責(zé)人、“十三五”蘇商未來(lái)之星等稱(chēng)號(hào)。從管理者到藥企掌門(mén)人，他華麗轉(zhuǎn)身大刀闊斧推進(jìn)改革，通過(guò)戰(zhàn)略重構(gòu)、機(jī)制創(chuàng)新和文化重塑，開(kāi)啟揚(yáng)子江 “二次創(chuàng)業(yè)”新征程；他全力打造“化、中、生+藥、醫(yī)、養(yǎng)、食、游”雙品牌戰(zhàn)略，以“健康中國(guó)”為引領(lǐng)，為集團(tuán)高質(zhì)量發(fā)展錨定方向；他聚焦品質(zhì)升級(jí)，持續(xù)守正創(chuàng)新，帶領(lǐng)揚(yáng)子江藥業(yè)朝著世界一流制藥企業(yè)邁進(jìn)。Mr. Xu Haoyu is currently the Secretary of the Party Committee, Chairman and General Manager of Yangtze River Pharmaceutical Group, Vice President of All-China Federation of Industry & Commerce Medical & Pharmaceutical Industry Chamber, Vice President of China Quality Association for Pharmaceuticals, Vice President of Jiangsu Federation of Industry and Commerce, Executive Vice President of Jiangsu Sushang Development Promotion Association, and President of Jiangsu Provincial Pharmacy Association. He has been awarded as one of the Top 10 Outstanding Young Entrepreneurs in Yangtze River Delta, National QC Excellent Quality Person, and Future Star of Jiangsu Entrepreneurs in the Thirteenth Five-Year Plan., etc.From an executive to the person in charge of a pharmaceutical group, he has made a gorgeous turn to deepen reform, and to start a new journey of Yangtze River Pharmaceutical Group through strategic restructuring, mechanism innovation and cultural reshaping; he has made every effort to build dual brand strategy of “Chemical Medicines, Traditional Chinese Medicines, Biological Medicines + Medicines, Medical Care, Health Preserving, Food, Tourism” to set the direction for the Group’s high-quality development under the guidance of Healthy China; focusing on quality upgrading, upholding fundamental principles and breaking new ground, he is leading Yangtze River Pharmaceutical Group to move towards a world-class pharmaceutical enterprise.